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Aortoduodenal fistula 5 years after endovascular
abdominal aortic aneurysm repair with the Ancure
stent graft
Blaine J. Ruby, MD, and Thomas H. Cogbill, MD, LaCrosse, Wis
We report a case of aortoduodenal fistula 5 years after uncomplicated endovascular abdominal aortic aneurysm repair.
The diagnosis was confirmed by abdominal computed tomography scan and esophagogastroduodenoscopy. The patient
was successfully treated with primary duodenal repair, removal of the infected graft, in situ placement of a bifurcated
graft, and omental interposition. Review of the literature identifies this as one of very few documented aortoduodenal
fistulas after endovascular aneurysm repair. Fistulization occurred despite accurate stent graft placement without
migration, endoleak, or aortic sac size enlargement on annual postoperative imaging studies. (J Vasc Surg 2007;45:834-6.)Aortoduodenal fistula is a rare entity. Primary aortoen-
teric fistula (AEF) has an incidence of 0.04% to 0.07%.1
Secondary AEF, a fistula that develops after open abdomi-
nal aortic aneurysm (AAA) repair, occurs after only 0.36%
to 1.6% of cases.1 Aortoduodenal fistula after endovascular
aneurysm repair (EVAR) is exceedingly rare, with only a
few other cases reported. We present a patient with aor-
toduodenal fistula 5 years after successful EVAR.
CASE REPORT
A 76-year-old man underwent uncomplicated EVAR for a
5.7-cm infrarenal AAA. The repair was performed using a
22-mm 16-mm Ancure (Guidant, Indianapolis, Ind) bifurcated
graft. Follow-up computed tomography (CT) scans at 2 months
and 14 months after EVAR confirmed shrinkage of the aneurysm
sac from 5.6 cm to 5.2 cm. Stabilization of aortic sac size at 5.5 cm
was demonstrated on surveillance ultrasound examinations at 26
months and 50 months after EVAR and on a CT scan at 38
months. The stent graft position was excellent, without migration,
and there was no evidence of endoleak on any of these five
surveillance studies.
Fifty-eight months after repair, abdominal pain, nausea, de-
creased appetite, and urinary retention developed in the patient 1
week after bilateral pulmonary emboli were diagnosed and treated
by full anticoagulation. The patient had not undergone any recent
angiographic, endoscopic, or dental procedures. A CT scan of the
abdomen and pelvis revealed air around the aortic stent graft (Fig 1).
Bloody emesis subsequently developed. An emergency esophago-
gastroduodenoscopy (EGD) was performed, an AEF was identi-
fied, and the patient underwent immediate operation.
At laparotomy, the aortic sac was acutely inflamed. After
proximal and distal control was obtained, the aortic aneurysm sac
was opened. It was filled with turbid, brown fluid and old clot. The
From the Department of Surgery, Gundersen Lutheran Medical Center.
Competition of interest: none.
Correspondence: Thomas H. Cogbill, MD, Department of Surgery,
Gundersen Lutheran, 1900 South Ave, C05-001, La Crosse, WI 54601
(e-mail: thcogbil@gundluth.org).
0741-5214/$32.00
Copyright © 2007 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2006.11.039
834endograft was not bile stained and was not in contact with the
fistula. The aortoduodenal fistula was between the third portion of
the duodenum and the native aneurysm sac. The proximal fixation
hooks were well seated in the aortic neck at least 4.0 cm above the
AEF. There was no evidence of stent or hook penetration through
the aortic wall. Both distal fixation points and the proximal fixation
point of the endograft were well incorporated.
The existing stent graft was explanted, and the aneurysm sac
was débrided and copiously irrigated. An in situ 18-mm  9-mm
Dacron graft, without antibiotic impregnation, was placed imme-
diately to limit ischemia time (Fig 2). Next, the duodenal portion
of the fistula was repaired primarily in two layers (Fig 3). The
greater omentum was interposed between the duodenum and the
aortic wall and a drain was placed.
Cultures were obtained and grew Clostridium perfringens,
Bacteroides fragilis, and Streptococcus spp at 48 hours. The patient
was treated with 17 days of intravenous vancomycin and 14 days of
intravenous fluconazole, followed by 13 days of intravenous ertap-
enem on the advice of two infectious disease consultants after a
review of all microbiologic cultures.
The patient’s postoperative course was complicated on day 7
by disruption of the right iliac anastomosis requiring ligation of the
right common iliac artery. An 8-mm knitted Dacron tube graft was
interposed between the right limb of the bifurcated graft and the
right common femoral artery. The abdomen was temporarily
closed, and a second-look laparotomy was done 2 days later. There
was no sign of sepsis, and the abdomen was closed.
The patient was subsequently discharged to home 5 weeks
later in stable condition on therapy with oral antibiotics. The
patient is doing well 13 months after discharge. He is currently
taking a suppression dose of oral clindamycin.
DISCUSSION
Aortoenteric fistula after EVAR is a rare complication.
To our knowledge, 10 cases have been previously de-
scribed. Two of the reported cases were associated with
graft migration and kinking that led to fistula formation.2,3
Another report described breakdown of the graft material
with development of a type III endoleak leading to fistuli-
zation.4 One fistula was noted in a patient who had a
persistent inflammatory periaortic mass after EVAR for
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type I endoleak after EVAR before fistulization occurred.6
One case was described in a patient with active Crohn’s
disease; fistulization may have resulted from a segment of
involved intestine.7 Finally, two cases were included in a
large review of EVAR complications, but no information
about the patients or other details were listed.8 Only two
other AEFs have been reported without any antecedent
complications after EVAR (Table).9,10
The aortoduodenal fistula in our case was not associ-
ated with an endoleak, graft migration, or increase in aortic
sac size during 5-year surveillance postoperatively. Even
after careful retrospective review of the five surveillance
studies, there was no evidence of endoleak or graft abnor-
malities.
The patient underwent successful primary duodenal
Fig 1. Abdominal computed tomography reveals copious air
around the aortic stent graft within the aneurysm sac.
Fig 2. Operative photograph of aortic stent graft explantation
from aortic sac. The proximal and distal fixation points were well
incorporated but did not prevent relatively easy removal of the
stent graft. (Patient’s head is to the right.)repair, removal of the infected graft, in situ replacementwith a Dacron bifurcated graft, and omental interposition.
Three of the previously reported 10 cases were managed
with intestinal repair, endograft explantation, and extra-
anatomic bypass, and four were managed with in situ aortic
grafting. One was managed with intravenous antibiotics
alone.7 The treatment for two patients was not described.
Perioperative mortality for these technically challenging
cases occurred in four (40%) of 10 patients.
AEF is a difficult problem to diagnose and treat. The
preoperative diagnosis is challenging. CT scan is only 33%
to 80% sensitive for AEF, and EGD may confirm the
diagnosis but does not eliminate it if no fistula is seen. The
primary reason for performing EGD is to exclude other
causes of upper gastrointestinal bleeding. Physicians must
rely on history and physical examination findings in addi-
tion to diagnostic tests to establish the diagnosis.
Controversy also exists about optimal treatment for
these patients. Traditional teaching recommends explanta-
tion of the infected graft and extra-anatomic bypass. More
recent studies suggest that patients can be treated with in
situ grafting using prosthetic graft material, resulting in
better 5-year patency and a greater limb salvage rate.11,12
The risk of AEF after EVAR is theoretically less than
after open AAA repair. AEF after open repair has an inci-
dence of up to 1.6%.1 EVAR leaves no exposed suture lines,
and because the aortic wall is not exposed or opened, the
retroperitoneal tissue remains intact, which leaves undis-
turbed, viable tissue between the aorta and the duodenum.
Suggested causes of AEF after EVAR include persistent
endoleak with associated increase in aortic sac size. Graft
migration, graft erosion, or adjacent organ injury from
protruding fixation hooks or metallic stents may also be
involved in the development of AEF. Other conditions
such as inflammatory AAA or Crohn’s disease may increase
Fig 3. Operative photograph of the fistula between the third
portion of the duodenum (surgical clamp tip is within the fistula,
surrounded by duodenal mucosa) and the aneurysm sac (black
arrow). The site of the fistula was 4 cm below the proximal stent
graft fixation point and did not involve fixation hooks or the
metallic stent.the risk of AEF after EVAR.No evidence was found of stent
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of the AEF in our patient. The most likely cause was
persistent aneurysm sac endotension in the absence of a
demonstrable endoleak. This resulted in a primary AEF
without direct involvement of the endograft.
Time between EVAR and diagnosis of AEF has been
variable. The previously reported cases occurred from 4 to
30 months after EVAR. Our case occurred 58 months after
EVAR, which is by far the longest postoperative interval
reported. The significance of this is unclear but does em-
phasize the continued need for surveillance after EVAR.
The true incidence of AEF after EVAR has yet to be defined
owing to the lack of comprehensive long-term data. With
our case and the 10 previous reports, it is clear that AEF
must remain in the differential diagnosis of any patient who
presents with upper gastrointestinal bleeding and abdomi-
nal pain after EVAR. These cases present a formidable
surgical challenge with significant perioperative morbidity
and mortality.
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er endovascular aneurysm repair
Time after
EVAR (mos) Vascular reconstruction Outcomes
 18 Aortobiiliac Alive @ 6 mos
 20 Aortobiiliac Alive @ 6 mos
 22 Axillobifemoral Alive @ 3.5 yrs
 5 Antibiotic therapy only Died
 9 ? Died
 30 None Died
6 Aortobiiliac Alive @ 7 mos
 23 Aortobiiliac Alive @ 1 yr
11 Axillobifemoral Alive @ 4 mos
 18 Axillobifemoral Died 6 days post-op
 58 In situ aortobiiliac graft Alive @ 13 mosla aft
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